Tone mix
Week by week 52 weeks
Share of Johnson & Johnson's 1,665 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Dec 22, 2025 · tone -47Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder-45
- Week of Jan 5, 2026 · tone +46Johnson & Johnson In Deal With Trump Administration To Cut Drug Prices, Get Tariff Exemption+44
- Week of Aug 24, 2026 · tone +68I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now+44
- Week of Oct 12, 2026 · tone -22Why Johnson & Johnson Stock Dropped Today-41
- Week of Jan 26, 2026 · tone +46Guggenheim Lifts Johnson & Johnson (JNJ) Outlook After Solid Q4 and 2026 Guide+37
- Week of Jan 12, 2026 · tone +37Here's What Lifted Johnson & Johnson (JNJ) in Q4+35
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Johnson & Johnson in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 28 | +31 |
| Last 30 sessions | 129 | +15 |
| Last 90 sessions | 469 | +23 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletOne Wealth Capital Management LLC Purchases 4,190 Shares of Johnson & Johnson $JNJNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| One Wealth Capital Management LLC Purchases 4,190 Shares of Johnson & Johnson $JNJ | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 27, 2026
3 headlines, average tone +63: 2 positive, 1 neutral and 0 negative. Showing all 3.
- econotimes.com · 1 outletJohnson & Johnson Reports 75% Response Rate in 50-mg Phase 1 Prostate Cancer CohortPositive
- www.dailypolitical.com · 1 outletJohnson & Johnson (NYSE:JNJ) Stock Has Average Price Target of $275.92 According to AnalystsPositive
- www.pr-inside.com · 1 outletBronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) ...Neutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Johnson & Johnson Reports 75% Response Rate in 50-mg Phase 1 Prostate Cancer Cohort | econotimes.com | 1 | Positive |
| Johnson & Johnson (NYSE:JNJ) Stock Has Average Price Target of $275.92 According to Analysts | www.dailypolitical.com | 1 | Positive |
| Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
9 headlines, average tone +40: 4 positive, 5 neutral and 0 negative. The 8 most widely carried stories are listed; the table holds all 9.
- www.ksl.com · 3 outletsJohnson & Johnson's prostate cancer drug shrinks tumors in early-stage trialPositive
- www.rttnews.com · 2 outletsJohnson & Johnson's JNJ-6143 Shows Strong Early Efficacy In Pretreated Advanced Prostate CancerPositive
- www.gdnonline.com · 2 outletsHealth: Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trialPositive
- www.fool.com · 2 outletsAmgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?Neutral
- econotimes.com · 1 outletJohnson & Johnson Reports Early JNJ-6143 Responses in Prostate Cancer TrialPositive
- seekingalpha.com · 1 outletJohnson & Johnson reports response rate for head, neck cancer treatment (JNJ:NYSE)Neutral
- www.dailypolitical.com · 1 outletSBI Securities Co. Ltd. Acquires 10,021 Shares of Johnson & Johnson $JNJNeutral
- www.dailypolitical.com · 1 outletWavvest Wealth LLC Purchases New Position in Johnson & Johnson $JNJNeutral
Show the table · 9 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial | www.ksl.com | 3 | Positive |
| Johnson & Johnson's JNJ-6143 Shows Strong Early Efficacy In Pretreated Advanced Prostate Cancer | www.rttnews.com | 2 | Positive |
| Health: Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trial | www.gdnonline.com | 2 | Positive |
| Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? | www.fool.com | 2 | Neutral |
| Johnson & Johnson Reports Early JNJ-6143 Responses in Prostate Cancer Trial | econotimes.com | 1 | Positive |
| Johnson & Johnson reports response rate for head, neck cancer treatment (JNJ:NYSE) | seekingalpha.com | 1 | Neutral |
| SBI Securities Co. Ltd. Acquires 10,021 Shares of Johnson & Johnson $JNJ | www.dailypolitical.com | 1 | Neutral |
| Wavvest Wealth LLC Purchases New Position in Johnson & Johnson $JNJ | www.dailypolitical.com | 1 | Neutral |
| 2,062 Johnson & Johnson $JNJ Shares Sold by Sowell Financial Services LLC | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
5 headlines, average tone +57: 3 positive, 2 neutral and 0 negative. Showing all 5.
- balticbusinessnews.com · 2 outletsJohnson & Johnson Deepens its Long-Term Commitment to Hong Kong Through OASES Strategic Enterprise CollaborationPositive
- econotimes.com · 1 outletMyeloma Foundation Launches U.S. Trial Network With Johnson & JohnsonPositive
- www.aol.com · 1 outletProcter & Gamble Jumps 6% as Earnings Beat Draws Defensive Buyers; Johnson & Johnson Rises 3%, Coca-Cola Ticks UpPositive
- www.foreignpolicyjournal.com · 1 outletCapital Group Core Balanced ETF (NYSE: CGBL) Opens New Position In Johnson & Johnson (NYSE: JNJ)Neutral
- www.aol.com · 1 outletJNJ Stock Has a New Growth Story, but One Business Needs to Catch UpNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Johnson & Johnson Deepens its Long-Term Commitment to Hong Kong Through OASES Strategic Enterprise Collaboration | balticbusinessnews.com | 2 | Positive |
| Myeloma Foundation Launches U.S. Trial Network With Johnson & Johnson | econotimes.com | 1 | Positive |
| Procter & Gamble Jumps 6% as Earnings Beat Draws Defensive Buyers; Johnson & Johnson Rises 3%, Coca-Cola Ticks Up | www.aol.com | 1 | Positive |
| Capital Group Core Balanced ETF (NYSE: CGBL) Opens New Position In Johnson & Johnson (NYSE: JNJ) | www.foreignpolicyjournal.com | 1 | Neutral |
| JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up | www.aol.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
6 headlines, average tone +8: 2 positive, 3 neutral and 1 negative. Showing all 6.
- www.fool.com · 3 outletsNot Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026Negative
- www.aol.com · 2 outletsJohnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500?Positive
- www.finanznachrichten.de · 1 outletJohnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026Positive
- www.themarketsdaily.com · 1 outlet7,115 Johnson & Johnson $JNJ Shares Bought by Sumitomo Mitsui DS Asset Management Company LtdNeutral
- www.insidermonkey.com · 1 outletJohnson & Johnson (JNJ) Drugs Lift Guidance, but Is 23 Times Earnings Fair?Neutral
- www.pr-inside.com · 1 outletBronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson ...Neutral
Show the table · 6 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 | www.fool.com | 3 | Negative |
| Johnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500? | www.aol.com | 2 | Positive |
| Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026 | www.finanznachrichten.de | 1 | Positive |
| 7,115 Johnson & Johnson $JNJ Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd | www.themarketsdaily.com | 1 | Neutral |
| Johnson & Johnson (JNJ) Drugs Lift Guidance, but Is 23 Times Earnings Fair? | www.insidermonkey.com | 1 | Neutral |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Johnson & Johnson, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.